Eurogenerics Eurogenerics
  • Home
  • About Us
    • Our Company
    • Activities
    • Certification
    • Work With Us
    • International Publication
  • Our Products
  • Our Services
  • Contact Us
Averkaz 5

Averkaz 5mg

Category: Montelukast Tag: Leukotriene Receptor Antagonist

Montelukast – Averkaz

5mg Chewable Tablet

DRP-6324

OPEN MARKET

  • Description
  • Additional information

Description

AVERKAZ is Montelukast, a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT1). The cysteinylleukotrienes (LTC4, LTD4, LTE4) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. Cysteinylleukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.

Supplied in 5mg Chewable Tablet in Alu-Alu Blister pack of 10’s (Box of 30’s).

Additional information

Registration Status

Registered

Drug Type

ANTI-ASTHMA / COPD

Principal

The Acme Laboratories Ltd.

Related products

  • Averkaz 10

    Averkaz 10mg

    Montelukast
  • Averkaz 4mg

    Montelukast

← View all products

  • Home
  • About Us
  • Our Products
  • Careers
  • Our Services
  • Contact Us
Euro Generics International Philippines © 2018